Inspira Technologies OXY B.H.N. (NASDAQ:IINN) Shares Down 10.5% – What’s Next?

Inspira Technologies OXY B.H.N. Ltd. (NASDAQ:IINN) shares fell 10.5% during mid-day trading on Thursday . The company traded as low as $1.65 and last traded at $1.70. Approximately 6,659,308 shares were traded during trading, an increase of 1,790% from the average session volume of 352,435 shares. The stock had previously closed at $1.90.

Analysts Set New Price Targets

Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of Inspira Technologies OXY B.H.N. in a report on Friday, April 10th. One analyst has rated the stock with a Sell rating, According to MarketBeat.com, the stock has an average rating of “Sell”.

Inspira Technologies OXY B.H.N. Stock Down 10.5%

The company’s 50-day moving average price is $1.14 and its two-hundred day moving average price is $0.87. The company has a debt-to-equity ratio of 0.08, a quick ratio of 1.30 and a current ratio of 1.56.

Institutional Trading of Inspira Technologies OXY B.H.N.

A number of large investors have recently bought and sold shares of IINN. Citadel Advisors LLC bought a new position in shares of Inspira Technologies OXY B.H.N. in the 3rd quarter worth about $105,000. Yorkville Advisors Global LP bought a new stake in shares of Inspira Technologies OXY B.H.N. during the 4th quarter valued at about $1,605,000. Finally, Kestra Advisory Services LLC bought a new stake in shares of Inspira Technologies OXY B.H.N. during the 4th quarter valued at about $71,000. 12.72% of the stock is currently owned by institutional investors and hedge funds.

About Inspira Technologies OXY B.H.N.

Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacture, and marketing of respiratory support technology to provide an alternative to invasive mechanical ventilation for the treatment of acute respiratory failure. Its lead product is the augmented respiration technology system, a respiratory support system comprising minimally invasive, portable dual lumen cannula, which is inserted into the jugular vein and utilizes extra-corporeal direct blood oxygenation to elevate and stabilize declining oxygen saturation levels.